Publications Page Hero Image
The Power of Continuing Medication Education to Enhance Health Care Providers’ Index of Suspicion of Rare Dermatologic Conditions

The Power of Continuing Medication Education to Enhance Health Care Providers’ Index of Suspicion of Rare Dermatologic Conditions

/ Blog, Outcomes, Poster, Rare Disease
Education about rare diseases is crucial to reducing time to diagnosis and providing optimal care for patients. Recently, PlatformQ Health worked with our strategic partner the National Organization for Rare Read More
PlatformQ Health Secures Two Posters at 2023 American Academy of Neurology Annual Meeting

PlatformQ Health Secures Two Posters at 2023 American Academy of Neurology Annual Meeting

/ Blog, Outcomes, Poster
The digital education firm PlatformQ Health had two posters accepted at the 2023 American Academy of Neurology Annual Meeting, held in Boston from April 22-27, 2023. The company regularly shares outcomes from its health care provider (HCP) and patient-focused educational programs. During the annual meeting, PlatformQ Health’s posters focused on the results of recent HCP educational programs focused on Rett syndrome and Alzheimer's disease. Read More
A Patient-Centric Outcomes Approach That Impacted 26 Million Patients in 2022 

A Patient-Centric Outcomes Approach That Impacted 26 Million Patients in 2022 

/ Blog, Outcomes, Poster
PlatformQ Health had 20 posters accepted at major medical and healthcare conferences during 2022. We’re pleased to share the posters, highlighting key outcomes from our educational initiatives across an array Read More
Online Education Sheds Light on Gaps in Care for Chronic Spontaneous Urticaria

Online Education Sheds Light on Gaps in Care for Chronic Spontaneous Urticaria

/ Blog, Outcomes, Poster
Patients with chronic spontaneous urticaria (CSU) often suffer with unresolved symptoms, despite numerous visits to different healthcare providers. In a recent poster presented at the 2023 American Academy of Allergy, Asthma, and Immunology, PlatformQ Health evaluated the impact of digital continuing medical education (CME) on optimizing diagnosis as well as antihistamine dosing.  Read More
Four-part Digital Education Fosters Clinical Practice Changes in Gastric and Gastroesophageal Junction Adenocarcinomas

Four-part Digital Education Fosters Clinical Practice Changes in Gastric and Gastroesophageal Junction Adenocarcinomas

/ Blog, Outcomes, Poster
Gastric or gastroesophageal junction (GEJ) adenocarcinomas are notoriously difficult to treat, but recently approved immune checkpoint inhibitors and HER2-directed antibody drug conjugates are improving outcomes for patients with these conditions. While these advances are a positive change, they do pose challenges for healthcare providers who need to learn about new regimens and practices. Read More
Navigating the New World of Microlearning: Reaching and engaging specialists

Navigating the New World of Microlearning: Reaching and engaging specialists

/ Blog, Insights
As many continuing medication education (CME) program funders will tell you, finding ways to reach medical specialists is often a conundrum. Not only is their time in high demand but they have a plethora of choices when it comes to continuing education. Read More
Winter 2022 Partnership Newsletter

Winter 2022 Partnership Newsletter

/ Blog, News
A Look Back on 2022 - Connecting patients, providers, and caregivers through education As we reflect on the past year, we are particularly grateful for the connections we made with Read More
Tethered Education Identifies Gaps in TNBC Care and Perceptions

Tethered Education Identifies Gaps in TNBC Care and Perceptions

/ Blog, Outcomes, Poster
Vast racial disparities exist in triple-negative breast cancer (TNBC), yet many patients and providers are aware of these issues. Women of the African Diaspora (WAD) are often diagnosed at a more advanced stage and experience higher rates of TNBC-related mortality. Though the TNBC treatment landscape has changed with the influx of new clinical data and newly approved treatments, there is much education needed to ensure patients and the medical community are aware of these advances.  Read More
Timelapse of Patient and Provider Surveys Reveals Valuable Insights for CLL Educational Needs

Timelapse of Patient and Provider Surveys Reveals Valuable Insights for CLL Educational Needs

/ Blog, Outcomes, Poster
Targeted treatment regimens have significantly improved overall survival for patients with chronic lymphocytic leukemia (CLL). The emergence of new options such as BTK inhibitors has shifted the treatment landscape significantly, bringing a pressing need for education for providers, patients, and caregivers. Read More
Four-part CME Series Empowers Clinicians Caring for Patients with Rare Diseases

Four-part CME Series Empowers Clinicians Caring for Patients with Rare Diseases

/ Blog, Insights
Patients with rare diseases are anxious to find a cure, yet roughly only half ever receive a proper diagnosis. Many of these patients return to their primary care providers (PCPs) frustrated. Read More
Two-part Educational Program Improves Physician Competency in Immunotherapies

Two-part Educational Program Improves Physician Competency in Immunotherapies

/ Blog, News, Outcomes, Poster
The growth of immunotherapies has shifted the standard of care for treating many solid tumors. As new indications are approved, there is a growing need for clinician education in this space. Read More
Engaging and Educating Rare Disease and Cancer Patients Online through Financial Literacy

Engaging and Educating Rare Disease and Cancer Patients Online through Financial Literacy

/ Blog, home-feed, Insights, pinned
More than half of Americans face financial difficulties paying for medical treatment, according to a recent study. This is particularly relevant in rare diseases and cancer and exacerbates health issues while causing mounting anxiety. Read More